RESUMO
To determine the sensitivity pattern of Staphylococcus au reus in surgical site infection after elective surgery. Cross sectional descriptive. January1, 2012 to May 31,2013. Patients with minor or major surgical site infection [SSI] were selected by the treating surgeons and swabs taken for culture and sensitivity testing on blood agar, chocolate agar and MacConkey's agar plates [incubated at 370C] aerobically. The suspected colonies were subjected to catalase test and later coagulase test to confirm as Staphylococcus au reus and tested for sensitivity against commonly used antibiotics. Staphylococcus au reus was isolated in 59.2% of positive cultures. The highest resistance of S.aureus was against Cefixime [95.1%] followed by Cefaclor [77.1%]. The least resistance was against Sulbactam and Cefoperazone [8.2%] followed by Sparfloxacin [11.5%] and Amikacin [16.4%]. S. au reus was variably resistant to other commonly used drugs. Staphylococcus aureus is sensitive to less commonly used drugs like combination of Sulbactan and Cefoperazone and Sparfloxacin. Resistance to commonly used drugs like Cefixime and Cefaclor exists in surgical site infection and needs appropriate measures for prevention and control
RESUMO
To determine safety of diode laser by studying post operative complications after endourological procedures in co-morbid patients. A descriptive study. Shalamar hospital, Lahore from June 2009 to June 2012. We studied post-operative complications [up to 3 months] in 3 groups [prostatic obstruction, bladder growths ,urethral strictures] of total180 patients with ASA III and IV. We assessed hematuria, UTI, abdominal pain, suprapubic discomfort, urinary retention, dysuria, incomplete procedure, cardiac or respiratory compromise, fluid overload, mortality, catheterization times and mean postoperative hospital stay In prostate group, mean age was 70.8 +/- 8.6 years and follow-up period was 3 months. Complications were: mild transient haematuria in 65 [100%], creamy urine in 50 [77%], urinary tract infection in 25 [38.4%], dysuria in 16 [24.6%], retreatment required in 06 [9.2%], suprapubic discomfort in 3 [4.5%], TURP syndrome in 1 [1.5%] and significant hemorrhage requiring blood transfusion in 1 [1.5%],. In urethral strictures, the complications were: microscopic hematuria in 80 [100%], urinary tract infection in 52 [65%] suprapubic discomfort in 9 [11.2%], dysuria in 6 [7.4%] mild transient hematuria in 5 [6.2%]. In bladder growths, the complications were: mild transient haematuria in 30 [85.7%], creamy urine in 19 [54.2%], suprapubic discomfort in 18 [51.4%], dysuria in 9 [25.7%], urinary UTI in 8 [22.8%], ablation performed in two sittings in 1 [2.8%]. No mortality in any group. Diode laser is a safe and useful modality in patients with co-morbidities [ASA III and IV]